“Also, in the current market context where we see that where there is some amount of weakness which is there, the large groups they are better placed to manage the …
Dipan Mehta, Director, Elixir Equities, says the best way to engage with the green energy sector is by investing in solar equipment manufacturers, particularly solar module and cell producers like …
Rahul Bothra, CFO, and Sriharsha Majety, MD & Group CEO, Swiggy, in conversation with ET Now post announcement of Q2 results. Bothra says while some of Swiggy competitors have been …
Anuj Kumar, Director & CEO, CAMS, says there has been some market correction and some flattening of the mood in the last two months. But as things come back, we …
Subramanian Sarma, Member of the Board, L&T, says there are currently two to three key themes: a) Ongoing development of traditional fossil fuels, particularly oil and gas; b)collective efforts to …
Shares of Suzlon Energy hit a 5% upper circuit at Rs 62.37 in Tuesday’s trade after global brokerage firm Morgan Stanley upgraded the stock to ‘Overweight’ from ‘Equal-weight’. While upgrading, …
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in …
Believing in Tata Group-owned Trent’s growth story, the global brokerage firm has initiated coverage on the stock with a target price of Rs 8,000 and a buy rating. The target …
Anish Shah, Group CEO & MD, Mahindra Group, says what is helping the company stay ahead of the industry is a function of the products that they have tried to …
Dipan Mehta, Director, Elixir Equities, says pharma could be one segment where investors should be overweight and that may surprise early on the earnings front as well. So, when one …